Chemotherapy-Induced Peripheral Neuropathy Market to Witness Significant Growth at a CAGR of 14.2% During the Forecast Period (2026-2036) as Novel Therapies Enter Late-Stage Development | DelveInsight

Positive

AI Analysis

Summary

DelveInsight projects the chemotherapy-induced peripheral neuropathy market will grow at a CAGR of 14.2% from 2026-2036, driven by novel therapies entering late-stage development. This is a market analysis report with no specific drug or company clinical data disclosed.

Importance:2/10

Sentiment:

0.50

market analysischemotherapy-induced peripheral neuropathyCIPNlate-stage developmentmarket growth

Related Companies

$DWTX

Read the original article

Published by yahoo_finance on June 16, 2026 4:31 PM

Read Original